1 The selectivity of (-)-discretamine for al-adrenoceptor subtypes was investigated by use of functional and binding studies in rat vas deferens, spleen and aorta, and in cultured DDTIMF-2 and AlO cells. 2 In prostatic portions of rat vas deferens, the competitive antagonists (-)-discretamine, 5-methylurapidil (5-MU) and prazosin inhibited contractions to noradrenaline (NA) with pA2 values of 6.21, 8.71 and 9.27, respectively. The irreversible antagonist, chloroethylclonidine (CEC, 100 tiM) failed to affect contractions to NA while nifedipine (1 jaM) blocked them almost completely.3 In rat spleen, the competitive antagonists (-)-discretamine, 5-MU and prazosin inhibited contractions to phenylephrine with pA2 values of 6.44, 7.19 and 9.45, respectively. CEC (100I1M) significantly reduced the maximum contraction to phenylephrine while nifedipine (1 jaM) did not affect it.4 In rat aorta, the competitive antagonists (-)-discretamine, 5-MU and prazosin inhibited contractions to NA with pA2 values of 7.60, 8.00 and 9.40, respectively. CEC also antagonized the contractions to NA in a competitive manner with a pA2 value of 6.10. Its selectivity among various al-adrenoceptor subtypes is a1A:a1B:aE1D =0.04:0.07:1.0.